$BURU
Nuburu, Inc.

2021 Q3 Form 10-Q Financial Statement

#000110465921139332 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q4 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $210.0K
YoY Change
Gross Profit -$80.00K
YoY Change
Gross Profit Margin
Selling, General & Admin $1.280M $390.0K
YoY Change
% of Gross Profit
Research & Development $570.0K
YoY Change
% of Gross Profit
Depreciation & Amortization $410.0K
YoY Change
% of Gross Profit
Operating Expenses $386.9K $260.0K $121.6K
YoY Change 218.33%
Operating Profit -$386.9K -$121.6K
YoY Change 218.33%
Interest Expense $18.21K $90.00K $20.00K
YoY Change -8.95%
% of Operating Profit
Other Income/Expense, Net $20.35M -$16.90M -$695.5K
YoY Change -3026.53%
Pretax Income $19.97M -$17.80M -$100.0K
YoY Change -20067.58%
Income Tax
% Of Pretax Income
Net Earnings $19.97M -$17.80M -$817.1K
YoY Change -2543.8%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $2.390M -$426.0K -$2.393K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $693.4K $2.200M $2.600M
YoY Change -73.33%
Cash & Equivalents $693.4K $2.246M $2.585M
Short-Term Investments
Other Short-Term Assets $174.8K $300.0K $300.0K
YoY Change -41.74%
Inventory
Prepaid Expenses $174.8K $275.7K
Receivables
Other Receivables
Total Short-Term Assets $868.2K $2.521M $2.900M
YoY Change -70.06%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $334.4M $334.3M $334.2M
YoY Change 0.06%
Other Assets
YoY Change
Total Long-Term Assets $334.4M $334.3M $334.2M
YoY Change 0.06%
TOTAL ASSETS
Total Short-Term Assets $868.2K $2.521M $2.900M
Total Long-Term Assets $334.4M $334.3M $334.2M
Total Assets $335.3M $336.8M $337.1M
YoY Change -0.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K
YoY Change
Accrued Expenses $3.266M $208.1K $400.0K
YoY Change 716.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.375M $334.1K $500.0K
YoY Change 575.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $27.02M $48.70M $11.70M
YoY Change 130.9%
Total Long-Term Liabilities $27.02M $48.70M $11.70M
YoY Change 130.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.375M $334.1K $500.0K
Total Long-Term Liabilities $27.02M $48.70M $11.70M
Total Liabilities $30.39M $49.01M $12.20M
YoY Change 149.11%
SHAREHOLDERS EQUITY
Retained Earnings -$29.34M -$46.38M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$29.34M -$46.38M -$29.30M
YoY Change
Total Liabilities & Shareholders Equity $335.3M $336.8M $337.1M
YoY Change -0.54%

Cashflow Statement

Concept 2021 Q3 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income $19.97M -$17.80M -$817.1K
YoY Change -2543.8%
Depreciation, Depletion And Amortization $410.0K
YoY Change
Cash From Operating Activities -$774.5K -$60.00K -$390.0K
YoY Change 98.58%
INVESTING ACTIVITIES
Capital Expenditures $320.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$334.2M
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 -$334.2M
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -270.0K 337.2M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -774.5K -60.00K -390.0K
Cash From Investing Activities 0.000 0.000 -334.2M
Cash From Financing Activities 0.000 -270.0K 337.2M
Net Change In Cash -774.5K -330.0K 2.550M
YoY Change -130.37%
FREE CASH FLOW
Cash From Operating Activities -$774.5K -$60.00K -$390.0K
Capital Expenditures $320.0K
Free Cash Flow -$1.094M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001814215
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39489
dei Entity Registrant Name
EntityRegistrantName
TAILWIND ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1288435
dei Entity Address Address Line1
EntityAddressAddressLine1
1545 Courtney Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90046
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
432-0610
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
693437
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2245798
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-695516
CY2020Q4 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2021Q3 us-gaap Liabilities
Liabilities
30391009
CY2020Q4 us-gaap Liabilities
Liabilities
49006778
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
174792
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
275652
CY2021Q3 us-gaap Assets Current
AssetsCurrent
868229
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2521450
CY2021Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
334403203
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
334321131
CY2021Q3 us-gaap Assets
Assets
335271432
CY2020Q4 us-gaap Assets
Assets
336842581
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3266204
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
208129
CY2021Q3 twnd Accrued Offering Costs
AccruedOfferingCosts
109000
CY2020Q4 twnd Accrued Offering Costs
AccruedOfferingCosts
126000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3375204
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
334129
CY2021Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
15318255
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
36975099
CY2021Q3 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29336113
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46380733
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-29335277
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-46379897
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
335271432
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
336842581
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
386940
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
121555
us-gaap Operating Expenses
OperatingExpenses
4694296
us-gaap Operating Expenses
OperatingExpenses
122555
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-386940
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-121555
us-gaap Operating Income Loss
OperatingIncomeLoss
-4694296
us-gaap Operating Income Loss
OperatingIncomeLoss
-122555
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
18214
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
20204
us-gaap Investment Income Interest
InvestmentIncomeInterest
82072
us-gaap Investment Income Interest
InvestmentIncomeInterest
20204
CY2020Q3 twnd Transaction Costs Associated With Initial Public Offering
TransactionCostsAssociatedWithInitialPublicOffering
715720
twnd Transaction Costs Associated With Initial Public Offering
TransactionCostsAssociatedWithInitialPublicOffering
715720
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-20336305
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-21656844
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20354519
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1000
us-gaap Profit Loss
ProfitLoss
17044620
us-gaap Profit Loss
ProfitLoss
-818071
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21738916
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-695516
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
19967579
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-817071
us-gaap Net Income Loss
NetIncomeLoss
17044620
us-gaap Net Income Loss
NetIncomeLoss
-818071
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-46379897
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
7282560
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-39097337
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10205519
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-49302856
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
19967579
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-29335277
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
24000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2328000
CY2020Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-30832344
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-817071
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-29297415
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-21656844
twnd Transaction Costs Associated With Initial Public Offering
TransactionCostsAssociatedWithInitialPublicOffering
715720
us-gaap Investment Income Interest
InvestmentIncomeInterest
82072
us-gaap Investment Income Interest
InvestmentIncomeInterest
20204
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-100860
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
327842
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3058075
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
57916
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1535361
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-392481
twnd Cash Invested In Trust Account
CashInvestedInTrustAccount
334215700
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-334215700
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
327531386
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
9700000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
52250
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
11300
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
337192836
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1552361
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2584655
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2245798
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
693437
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2584655
twnd Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
402480
twnd Deferred Offering Costs Paid Through Related Party Debt
DeferredOfferingCostsPaidThroughRelatedPartyDebt
52250
twnd Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
11697550
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46380733
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-46379897
twnd Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
334215700
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2020Q4 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
334215700
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
334215700
CY2020Q4 twnd Temporary Equity Proceeds Allocated To Warrants
TemporaryEquityProceedsAllocatedToWarrants
12700197
twnd Temporary Equity Proceeds Allocated To Warrants
TemporaryEquityProceedsAllocatedToWarrants
12700197
CY2020Q4 twnd Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
18132174
twnd Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
18132174
CY2020Q4 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
30832371
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
30832371
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
334215700
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
334215700
twnd Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
18132174
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
950000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
59000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
26410785
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2021Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q3 twnd Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11697550
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1
CY2021Q3 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
1001
CY2021Q3 twnd Cash Held In Trust Account
CashHeldInTrustAccount
334402202
CY2020Q4 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
1138
CY2020Q4 twnd Cash Held In Trust Account
CashHeldInTrustAccount
334319993
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13580000
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3686000
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
9894000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
9894000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
9894000
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
9894000

Files In Submission

Name View Source Status
0001104659-21-139332-index-headers.html Edgar Link pending
0001104659-21-139332-index.html Edgar Link pending
0001104659-21-139332.txt Edgar Link pending
0001104659-21-139332-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twnd-20210930.xsd Edgar Link pending
twnd-20210930x10q.htm Edgar Link pending
twnd-20210930x10q_htm.xml Edgar Link completed
twnd-20210930xex31d1.htm Edgar Link pending
twnd-20210930xex31d2.htm Edgar Link pending
twnd-20210930xex32d1.htm Edgar Link pending
twnd-20210930xex32d2.htm Edgar Link pending
twnd-20210930_cal.xml Edgar Link unprocessable
twnd-20210930_def.xml Edgar Link unprocessable
twnd-20210930_lab.xml Edgar Link unprocessable
twnd-20210930_pre.xml Edgar Link unprocessable